Adial Pharmaceuticals, Inc. Life Settlement Contracts, Investment Method, Carrying Amount
Adial Pharmaceuticals, Inc. (ADIL) had Life Settlement Contracts, Investment Method, Carrying Amount of EUR 410.00 thousand as of 2022-04-28, per its 10-K filed 2023-03-30.
Discontinued › Notes
us-gaap:LifeSettlementContractsInvestmentMethodCarryingAmount · last filed 2023-03-30
- 2022-04-28: Life Settlement Contracts, Investment Method, Carrying Amount 410.00K EUR.
EUR
| Period end | Life Settlement Contracts, Investment Method, Carrying Amount |
|---|---|
| 2022-04-28 | 410.00K EUR 10-K · filed 2023-03-30 |
USD
| Period end | Life Settlement Contracts, Investment Method, Carrying Amount |
|---|---|
| 2022-04-28 | $454.03K 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |